Section 43-15-31.4 - Limited prescriptive practices1. A pharmacist has limited prescriptive practices to initiate or modify drug therapy following diagnosis or established protocols by a licensed physician or an advanced practice registered nurse, under the supervision of the licensed physician or advanced practice registered nurse, in accordance with this section. The licensed physician, advanced practice registered nurse, and the pharmacist must have access to the patient's appropriate medical records. The care provided to the patient by the pharmacist must be recorded in the patient's medical records and communicated to the licensed physician or the advanced practice registered nurse.2. The licensed physician or advanced practice registered nurse, and the pharmacist, shall prepare a collaborative agreement concerning the scope of the pharmacist's prescriptive practices and shall update the agreement if the scope of the pharmacist's prescriptive practices is modified. The collaborative agreement, or an amendment to the agreement, is effective if executed by the licensed physician or advanced practice registered nurse, and the pharmacist.3. The collaborative agreement may be between a medical director and pharmacist-in-charge. The medical director and pharmacist-in-charge shall document and update the agreement for any physician, advanced practice registered nurse, and pharmacist covered under the agreement.4. A collaborative agreement must be made available to the respective licensing boards of the parties to the agreement.5. The collaborative agreement must include a provision that requires the pharmacist to immediately notify the licensed physician or advanced practice registered nurse if the pharmacist initiates or modifies a drug therapy.Amended by S.L. 2019, ch. 352 (SB 2231),§ 1, eff. 8/1/2019.Amended by S.L. 2015, ch. 297 (HB 1153),§ 16, eff. 8/1/2015.Amended by S.L. 2015, ch. 295 (SB 2173),§ 1, eff. 8/1/2015.